ARCHIVES

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

This article is from The Cancer Letter archive.

Vol. 06 No. 39 | October 3, 1980

Download PDF Visit The Full Archive

Related Articles

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

In Brief: Some Cancer Centers Funded At “Recommended” Levels For Fiscal 1981, But There Was A Catch

October 30, 1981

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010